Tag: D.C. cannabis sales
-
April D.C. medical cannabis program sales rise out of slump
D.C.’s medical cannabis program sees sales rise in April, driven by new dispensaries D.C.’s medical cannabis program is showing signs of life after a rough year. Sales in April reached their highest level in nine months, according to a report by the Alcohol Beverage and Cannabis Administration (ABCA). This upswing is likely due in part…
-
Slight growth in D.C. patient registrations in March overshadowed by continued decline in medical cannabis sales
D.C.’s medical cannabis market sees minor growth despite lower sales A slight glimmer of hope for The District of Columbia’s medical cannabis market came in the form of a slight uptick in patient registrations in the program, according to new data. Since Maryland’s adult use market launched last July, D.C. has seen an overall decline…
-
D.C. medical cannabis market slumps as February sales hit four-year low
D.C. patient expirations outpace new registrations as medical sales continue decline The District of Columbia’s medical cannabis market is facing a period of decline, with February dispensary sales reaching their lowest point in four years. This trend comes alongside a drop in the number of patients served and an expiration of nearly 1,850 patient certifications…
-
Patient exodus and slower sales cast clouds over D.C. market
D.C. patient expirations outpace new registrations as medical sales continue decline Cultivation and manufacturing revenue in D.C.’s medical cannabis program continue to be below 2023, but they are growing slowly after hitting a low last fall. However, retail sales fell to their lowest point in four years last month, according to ABCA monthly revenue report.…
-
D.C. medical cannabis sales close out 2023 with six-month high
Six-month high in D.C. medical cannabis sales While overall sales haven’t reached pre-Maryland adult-use launch levels, D.C.’s medical cannabis market showed signs of stability in December 2023. Total sales reached nearly $3 million, marking the highest monthly figure since Maryland’s recreational market opened in July. Interestingly, patients benefiting from reduced licensing fees contributed over $300,000,…
-
D.C. medical cannabis sales continue to slow as out-of-state patient registration continues decline
A steady decline in sales continues D.C. released the monthly medical cannabis program metrics for November, revealing a continued drop in dispensary sales since the March program record high. Out-of-state and non-resident temporary patient registrations continue to decline, eclipsing the slight growth in D.C. medical patient registrations. The program sold a little more than $4.6…
-
New cannabis manufacturer October sales save D.C. program from 2023 low
Sales continue to drop D.C. released the monthly medical cannabis program metrics for October, revealing a slight drop in dispensary sales and the second consecutive monthly drop over $300,000 in cultivation sales. But due to newly included manufacturer sales of $761,330, D.C.’s medical program was able to reach a four month high for revenue. The…
-
D.C. hit $4.4 million in medical cannabis September revenue
Sales are steady but sloping down D.C. released the monthly medical cannabis program metrics yesterday, revealing a slight rise in dispensary sales and over a $300,000 drop in cultivation sales in September. The program sold a total of $4.4 million in cannabis products overall. It’s important to note that these metrics do not include the…